Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...

In 2024, the banned BLA emerged as a key perpetrator of terrorist violence in Pakistan. According to the Pakistan Security ...

Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the FDA has ...

Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the U.S. FDA has ...

Recent attacks by BLA and BLF in Balochistan claim civilian lives. Details on incidents, victim accounts, and security ...

Replimune Group, Inc. REPL announced that the FDA has accepted the biologics license application (BLA) for its lead pipeline ...

On the 14th of January, iFX EXPO Dubai 2025, MENA’s #1 online trading industry event, kicked-off its remarkable 2+ days of FX ...

A report by international organization Wilson Center has made startling revelations about the BLA exploiting women for ...

The FDA has accepted a BLA for treatment with RP1 in combination with Opdivo for patients with advanced melanoma who have ...

The investigational advanced melanoma combination therapy consisting of RP1 and nivolumab have a PDUFA action date of July 22 ...

On January 14, iFX EXPO Dubai 2025, the leading online trading event in MENA, kicked off a dynamic 2+ days of FX and Fintech ...